RVMD
Revolution Medicines IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$32.22B
P/E Ratio
—
EPS
$-7.11
Beta
1.41
52W High
$156.25
52W Low
$34.00
50-Day MA
$125.61
200-Day MA
$84.58
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Revolution Medicines Inc
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | 742,000 |
| Gross Profit (TTM) | $-1.13B |
| EBITDA | $-1.38B |
| Operating Margin | 0.00% |
| Return on Equity | -76.70% |
| Return on Assets | -37.50% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $7.49 |
| Price-to-Book | 21.48 |
| Price-to-Sales (TTM) | 9035.10 |
| EV/Revenue | 8370.02 |
| EV/EBITDA | -9.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -95.20% |
| Shares Outstanding | $212.60M |
| Float | $194.17M |
| % Insiders | 1.90% |
| % Institutions | 95.44% |
Historical Volatility
HV 10-Day
29.15%
HV 20-Day
54.99%
HV 30-Day
114.08%
HV 60-Day
83.99%
HV Rank
97.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($182.86 target)
4
Strong Buy17
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026